Data protection Impressum

Life sciences

Vaud-based biopharma Oculis has secured USD 59 million to extend operations into 2026, following a successful listing on NASDAQ Iceland Main Market.

Oculis announces completion of oversubscribed USD 59 million registered direct offering

15 April 2024

Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment through 3D printing.

Swibrace advances to clinical phase with innovative 3D-printed wrist braces

15 April 2024

With CHF 7.75 million from the BRH Foundation, the University of Bern and Insel Gruppe have launched a professorship to innovate in rehabilitation.

University of Bern introduces endowed professorship in interdisciplinary rehabilitation

15 April 2024

Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug development.

Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment

9 April 2024

Sitem Startup Club (SSC) has officialized a partnership with CSEM, uniting Bern's medtech ecosystem with engineering excellence for transformative healthcare solutions.

Sitem Startup Club and CSEM forge a strategic partnership to propel medtech innovation

8 April 2024

This funding is poised to extend the company's financial runway into mid-2025, as it gears up for the approval and launch of pioneering products designed to enhance the lives of individuals with spinal cord injuries (SCI).

ONWARD Medical secures EUR 20 million to expand its spinal cord injury therapies

26 March 2024

This financial infusion is set to bolster the clinical advancement of Volumina Medical’s injectable dermal filler, Adipearl.

Volumina Medical raises USD 21 million to advance regenerative medicine

25 March 2024

This funding follows closely on the heels of the completion of enrollment of Spineart’s BAGUERA® C Intervertebral Disc (IDE) studies, which aim to push the boundaries of spinal surgery through extensive research and development efforts.

Spineart raises CHF 20 million to push the boundaries of spinal surgery

20 March 2024

The ARTORG team investigates how a special balloon catheter must be used so that drugs can reach and dissolve blood clots in the smallest branches. To do this, they combine engineering know-how, fluid mechanics and biological expertise.

Bern researchers unveil groundbreaking cardiac care method

19 March 2024

Alithea Genomics, which emerged from the EPFL in 2020, has distinguished itself within the life sciences sector with its cutting-edge RNA sequencing solutions.

Alithea Genomics embarks on next-phase growth with CHF 2.8 million funding

18 March 2024

1 … 6 7 8 9 10 11 12 13 14 … 39